International Medical Group has partnered with eMed to offer eMed’s at home Covid-19 tests in bulk to IMG group customers traveling internationally.
IMG group customers can now request the quantity of tests they need and eMed will ship the tests directly to their location.
Each test is self-administered and supervised during a telehealth visit by an eMed Telehealth Proctor who oversees sample collection, the testing process, and certifies the results. Upon completing the test, users receives an email with their validated digital lab report and a digital health pass to an app on their smart device if their test result is negative. For individuals with a positive test result, eMed’s Test-to-Treat services allow them to meet via telehealth with a clinician to potentially receive treatment, such as a prescription, all for the same price.
Amanda Winkle, chief commercial officer at IMG, said: “We are pleased to partner with eMed to offer our groups a simple and convenient way of testing for Covid-19 prior to their travels.
“Since 1990, we’ve provided our groups with industry-leading medical benefits and services, and this is just one more way that we can be there for them while they are away from home.”
Dr Patrice Harris, co-founder and CEO of eMed, added: “We have provided tens of millions of virtually proctored at-home Covid-19 tests to consumers, businesses, and governments, and we are excited to provide this testing solution to IMG customers who are traveling abroad.
“With test results available in 15 minutes, we are proud to offer customers a convenient, reliable Covid-19 testing option they can trust without the hassle of having to find testing in a foreign country.”